Avanos Medical, Inc.AVNSNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-48.01%
2024467.81%
2023-79.61%
20227.99%
2021392.07%
202081.85%
201935.75%
2018-292.77%
2017-36.76%
2016487.13%